Immune restoration and CD4+ T-cell function with antiretroviral therapies
Author:
- 1 February 2001
- journal article
- review article
- Published by Wolters Kluwer Health in AIDS
- Vol. 15, S11-S15
Abstract
To review the current understanding of the details and mechanisms of immune restoration that follows administration of suppressive antiretroviral therapies to persons with chronic HIV-1 infection. A first-phase cellular increase often includes increases in multiple circulating lymphocyte populations and is largely attributable to rapid redistribution of cells from lymphoid tissue. A second slower phase is largely comprised of naïve cell increases that may reflect cells newly produced in the thymus. Improvement in CD4+ cell function is demonstrable but functional restoration is incomplete. Immunization can enhance the restoration of CD4+ cell-dependent responses, and the magnitude of restoration is related in part to the degree to which HIV-1 replication and immune activation are controlled. Despite the incomplete nature of immune restoration seen after suppression of HIV-1 replication in chronic infection, clinical benefits of these responses are reflected in decreased HIV-1-related opportunistic infections and mortality. The effects of these therapies on the occurrence of non-Hodgkins lymphoma are less apparent. Suppression of HIV-1 replication results in both laboratory and clinical evidence of immune restoration. Although incomplete, this immune restoration provides 'breathing room' to develop better-tolerated antiviral therapies and therapies designed to enhance immune function.Keywords
This publication has 40 references indexed in Scilit:
- Thymic Size and Lymphocyte Restoration in Patients with Human Immunodeficiency Virus Infection after 48 Weeks of Zidovudine, Lamivudine, and Ritonavir TherapyThe Journal of Infectious Diseases, 2000
- Response to immunization with recall and neoantigens after prolonged administration of an HIV-1 protease inhibitor-containing regimenAIDS, 2000
- Different immunologic profiles characterize HIV infection in highly active antiretroviral therapy-treated and antiretroviral-naïve patients with undetectable viraemiaAIDS, 2000
- Prolonged Suppression of Human Immunodeficiency Virus Type 1 (HIV‐1) Viremia in Persons with Advanced Disease Results in Enhancement of CD4 T Cell Reactivity to Microbial Antigens but Not to HIV‐1 AntigensThe Journal of Infectious Diseases, 1999
- Protease inhibitor and triple-drug therapyAIDS, 1998
- In vivo analysis of Fas/FasL interactions in HIV-infected patients.Journal of Clinical Investigation, 1998
- No evidence for proliferation in the blood CD4+ T-cell pool during HIV-1 infection and triple combination therapyAIDS, 1998
- Absence of Recoverable Infectious Virus and Unique Immune Responses in an Asymptomatic HIV + Long-Term SurvivorAIDS Research and Human Retroviruses, 1994
- HIV induces thymus depletion in vivoNature, 1993
- A Phase I Evaluation of the Safety and Immunogenicity of Vaccination with Recombinant gp160 in Patients with Early Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1991